Trademark: 97428106
Word
EVOQ
Status Date
Wednesday, February 14, 2024
Filing Date
Wednesday, May 25, 2022
5 (Based on Intent to Use) Diagnostic preparations for medical purposes for detecting the presence of autoimmune disorders and conditions; pharmaceutical preparations and products for immunotherapy treatments; pharmaceutical preparations and products for the treatments of cancers and autoimmune diseases
44 (Based on Use in Commerce) Consultancy in the field of the medical treatment of autoimmune diseases and cancers; medical treatment of autoimmune disorders and conditions; medical testing and diagnostic services for treatment purposes in the field of autoimmune disorders and conditions; immunotherapy treatments; immunotherapy treatments for cancers and autoimmune disease; medical diagnostic testing, monitoring, and reporting services
42 (Based on Use in Commerce) Medical research in the field of autoimmune diseases and cancers; medical research and development in the field of development of immunotherapy treatments
Jun 1, 2022
New Application Office Supplied Data Entered
May 28, 2022
New Application Entered
Jan 12, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 12, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 12, 2023
Teas Change Of Correspondence Received
Mar 13, 2023
Assigned To Examiner
Mar 27, 2023
Non-Final Action Written
Mar 27, 2023
Non-Final Action E-Mailed
Mar 27, 2023
Notification Of Non-Final Action E-Mailed
Jun 27, 2023
Teas Response To Office Action Received
Nov 30, 2023
Assigned To Lie
Dec 1, 2023
Correspondence Received In Law Office
Dec 1, 2023
Teas/Email Correspondence Entered
May 2, 2024
Correspondence Received In Law Office
May 2, 2024
Teas/Email Correspondence Entered
May 2, 2024
Teas Request For Reconsideration Received
Feb 14, 2024
Notification Of Final Refusal Emailed
Feb 14, 2024
Final Refusal Written
Feb 14, 2024
Final Refusal E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
